FORWARD PHARMA A/S: Financial statements 2023
CVR: 28865880
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
FORWARD PHARMA A/S (CVR 28865880) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -6,130,606 and a net result of DKK -3,832,516 compared with DKK -31,482,847 the year before. Equity in the 2023 report amounted to DKK 426,445,777. The solvency ratio was 60.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -6,130,606
- Profit/Loss
- DKK -3,832,516
- Equity
- DKK 426,445,777
- Total Assets
- DKK 704,684,594
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -6.1 mio. | -3.8 mio. | 426.4 mio. | 2 |
| 2022 | - | -11.6 mio. | -31.5 mio. | 430.4 mio. | 2 |
| 2021 | - | -10.8 mio. | -12.3 mio. | 461.9 mio. | 2 |
| 2020 | - | -7.8 mio. | -42.2 mio. | 474.1 mio. | 2 |
| 2019 | - | -6 mio. | -28.5 mio. | 515.9 mio. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
FORWARD PHARMA A/S has published its annual report for 2022. Gross profit came to DKK -11,631,794, and the net result was DKK -31,482,847.
As of June 8, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of FORWARD PHARMA A/S.
As of June 8, 2023, EY Godkendt Revisionspartnerselskab has stepped down as auditor of FORWARD PHARMA A/S.
About FORWARD PHARMA A/S
FORWARD PHARMA A/S was a Danish company of the type Aktieselskab based in Hellerup, founded in 2005. The company has been dissolved on 26 November 2025. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 4 employees (2018). In 2024, the company reported a gross profit of DKK -9,457,909 and a net result of DKK 75,927,645 compared with DKK -3,832,516 the year before. Equity in the 2024 report amounted to DKK 488,330,233.